Clinical Trial Platform for Startup Biotech

Clinical trial platform for startup biotech: EDC with eConsent, ePRO, and 21 CFR Part 11–aligned controls. Speed, flexibility, no enterprise overhead.

21 CFR Part 11–aligned · HIPAA-aligned security · No credit card required

Overview

Clinical Trial Platform for Startup Biotech

Startup biotech needs a clinical trial platform that emphasizes speed, flexibility, and avoiding enterprise implementation overhead—one system for EDC, eConsent, and ePRO with rapid build and 21 CFR Part 11–aligned controls. What slows teams down is enterprise implementation cycles and heavy change control; what modern tools change is study builder and rapid deployment so you can launch early-phase trials without enterprise overhead. Capture fits startup biotech with one platform and documentation to support sponsor validation when required.

What slows startup biotech down

Enterprise EDC is built for large sponsors and long implementation. Startup biotech needs speed and flexibility: rapid build, flexible amendments, and pricing that scales—with 21 CFR Part 11–aligned controls so you don’t compromise compliance. A platform for startup biotech avoids enterprise implementation overhead and delivers one system for consent and data capture so you can reach first patient or first dose faster.

What modern tools change

  • Rapid study build and deployment; avoid enterprise implementation overhead
  • Study builder and flexible amendments when your process allows
  • One platform for EDC, eConsent, ePRO, and safety; one audit trail
  • 21 CFR Part 11–aligned controls and HIPAA-aligned security
  • Pricing that scales with study size; documentation for validation (Enterprise)

Pain points

  • Enterprise implementation cycles that delay study start
  • Heavy change control for protocol and form updates
  • Pricing and contracts built for large sponsors
  • Need for speed and flexibility without enterprise overhead

Capture fit

  • Single platform for EDC, eConsent, ePRO, and safety; rapid build and flexible amendments
  • 21 CFR Part 11–aligned controls and HIPAA-aligned security
  • Built for early-phase and startup biotech; documentation for validation (Enterprise)
  • See how it works or book a demo

FAQ

Questions we hear a lot

What clinical trial platform fits startup biotech?
Look for one platform for EDC, eConsent, and ePRO with rapid build, flexible amendments, and 21 CFR Part 11–aligned controls—without enterprise implementation overhead. Capture is built for early-phase and startup biotech.
Is Capture 21 CFR Part 11–aligned?
Yes. Capture is designed with 21 CFR Part 11–aligned controls and HIPAA-aligned security. We provide documentation to support sponsor validation when required (Enterprise).

Ready to see Capture in action?

Explore the platform with a free sandbox. No sales call required.